🔎 Trials Near Me

Gara Jalqabaatti › Myelodysplastic Syndromes › Kentucky › Louisville

Qorannoo klinikaalii Myelodysplastic Syndromes Louisville, KY keessatti

Qorannoo 5 Myelodysplastic Syndromes f Louisville fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06577441

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Namoota walitti qabaa jiraSadarkaa 3
  • Norton Cancer Institute, Louisville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07422480

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Namoota walitti qabaa jiraSadarkaa 3
  • Norton Cancer Institute, Louisville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT06499285

Qorannoo Myelodysplastic Syndromes magaalota biroo keessatti

Qorannoo biroo Louisville keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.